Company_Context
Basic Materials
Pharmaceutical Preparations
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Signal_Window
Headline metrics use exact calendar-day windows.
2 directional transactions in 90D
Code P purchases and code S sales are measured from 2026.07.20 — 2026.10.17.
-$437K
Open-market buys minus sales2026.10.02
Latest available filing9
Reporting entities in windowNo 90D buyer
No open-market buys in 90DMassacesi Cristian
$403.5KAnalysis of eligible SEC Form 4 activity for BMY indicates a bearish 90-day signal. The selected window contains transactions from 9 distinct reporting insiders, with aggregate nominal activity of $2.64M.
Open-market purchases minus open-market sales produce a negative net flow of $0.44M. Open-market executions represent the majority of measured nominal activity in this window, making the directional flow more representative of voluntary trading activity.
The largest open-market sale in the selected window was attributed to Massacesi Cristian (EVP,Chief Med Offr,Head of Dev). Form 4 activity provides useful ownership context, but it should not be treated as a standalone prediction of future price performance.
Enriched_Research_Context
These indicators use normalized SEC roles, issuer metadata, cluster detection and post-filing market prices already calculated by the data pipeline.
Basic Materials
Pharmaceutical Preparations
0
Clustered open-market purchase records in the recent filing sample.
Unlock a $15 subscription discount
For eligible new users purchasing a subscription through this link. TradingView terms apply.
Affiliate link — InsiderAlpha may earn a commission at no additional cost to you.
Recent_Filing_History
This table shows recent filing history and is not restricted by the selected 90D headline signal window.
The selected 90-day window contains 9 distinct reporting insiders with eligible transactions for BMY. This count changes when a different signal window is selected.
Open-market selling volume ($0.44M) currently exceeds buying volume ($0.00M), indicating net liquidation by insiders.
No eligible open-market purchases were reported for BMY during the last 90 calendar days.
Elkins David V
OPEN_MARKET_SALECFO · 2026.04.01
30D
-4.7%
90D
-5.7%
180D
PENDING
Performance uses the latest matured open-market record in this sample. It describes subsequent market movement and does not imply that the filing caused the price change.